FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if the exposure to all the three active cytotoxic
agents (FOLFOXIRI regimen) is superior in terms of response rate to conventional chemotherapy
with the FOLFIRI regimen as first-line treatment of metastatic colorectal cancer patients.